GLOBAL HEMATOLOGY | TIF Publishes EHA 2026 Key Takeaways
The Thalassaemia International Federation (TIF) has published a Special Report detailing its high-impact participation in the 31st European Hematology Association (EHA) Annual Congress, held as a hybrid event from June 11–14, 2026, in Stockholm, Sweden.
As a vital annual milestone, EHA2026 united thousands of hematologists, clinical researchers, and advocates from across the globe to address critical breakthroughs in the research, management, and cure of hematological diseases.
This year’s agenda featured crucial discussions on thalassemia, sickle cell disease, and other rare anemias, areas where TIF actively supports patient and medical communities through targeted education and international advocacy.
This newly prepared Special Report provides a comprehensive overview of TIF’s key contributions, strategic activities, and vital takeaways from this prestigious global forum.
